Novel quinazolin-2-yl 1, 2, 3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study

NFM El Hamaky, A Hamdi, WA Bayoumi, AA Elgazar… - Bioorganic …, 2024 - Elsevier
In our study, a series of quinazoline-1, 2, 3-triazole hybrids (14a-r) have been designed and
synthesized as multi-target EGFR, VEGFR-2, and Topo II inhibitors. All synthesized hybrids …

Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 …

S Shaaban, HA Althikrallah, A Negm, AA Elmaaty… - RSC …, 2024 - pubs.rsc.org
Organoselenium (OSe) agents hold promise for preventing cancer due to their potential
ability to fight cancer development and protect cells from oxidative damage. Herein, OSe …

Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic …

S El-Kalyoubi, MM Khalifa, MT Abo-Elfadl… - Journal of Enzyme …, 2023 - Taylor & Francis
A new wave of dual Topo I/II inhibitors was designed and synthesised via the hybridisation
of spirooxindoles and pyrimidines. In situ selenium nanoparticles (SeNPs) for some …

Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy (2006-present)

Y An, X Lv, S Xu, H Li, P Zheng, W Zhu… - European Journal of …, 2025 - Elsevier
The epidermal growth factor receptor (EGFR) is a pivotal member of the epidermal growth
factor receptor family, exerting crucial regulatory influence on cellular physiological …

Discovery of pyran annulated heterocyclic scaffolds linked to carboxamide fragments: Anticancer evaluation, topoisomerase I/II, tyrosine kinase receptor inhibition and …

AM Fouda, RA El-Eisawy, MAA El-Nassag… - Journal of Molecular …, 2024 - Elsevier
A class of 4H-benzo [h] chromene (4a-h) and 1H-benzo [f] chromene (6a-h) derivatives
linked to carboxamide/carbothioamide at the 3/2-positions were designed and synthesized …

Machine learning-based approach to develo** potent EGFR inhibitors for breast cancer─ design, synthesis, and in vitro evaluation

H Nada, AR Gul, A Elkamhawy, S Kim, M Kim… - ACS …, 2023 - ACS Publications
The epidermal growth factor receptor (EGFR) is vital for regulating cellular functions,
including cell division, migration, survival, apoptosis, angiogenesis, and cancer. EGFR …

Rational design and eco-friendly one-pot multicomponent synthesis of novel ethylidenehydrazineylthiazol-4 (5H)-ones as potential apoptotic inducers targeting wild …

EM Abbass, AA Al-Karmalawy, M Sharaky… - Bioorganic …, 2024 - Elsevier
A novel series of ethylidenehydrazineylthiazol-4 (5H)-ones were synthesized using various
eco-friendly one-pot multicomponent synthetic techniques. The anticancer activity of …

Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl) thio) acetamide candidates as telomerase/JAK1/STAT3/TLR4 inhibitors: In vitro …

MA Shaldam, MHA Mousa, HO Tawfik… - Bioorganic …, 2024 - Elsevier
In this work, additional effort was applied to design new BIBR1532-based analogues with
potential inhibitory activity against telomerase and acting as multitarget antitumor candidates …

Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers

AA Gaber, M Sharaky, AA Elmaaty… - Future Medicinal …, 2023 - Taylor & Francis
Aim: Our objective was to design and synthesize a new range of pyrazolopyrimidines while
maintaining the key pharmacophoric features of EGFR tyrosine kinase inhibitors. Materials & …

Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA …

HR Nofal, AA Al‐Karmalawy, AA Elmaaty… - Archiv der …, 2024 - Wiley Online Library
A series of tetrahydrobenzo [b] thiophene derivatives was designed and synthesized as dual
topoisomerase (Topo) I/II inhibitors implicating potential DNA intercalation. Ethyl‐2‐amino‐3 …